Third, because the low incidence of ICI-DM as an adverse effect of PD-1/PD-L1 inhibition makes it difficult to study the patient cohort at risk for developing such complications, further studies, including a large number of cases, are needed. Here, CD274 is linked to diabetes mellitus.